MedTrace Logo

Validation of an App in the Elderly Population With Diabetes Mellitus.

NCT07591415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-15

No results posted yet for this study

Summary

A randomized clinical trial comparing the intervention group, which will use a mobile app, with the control group (without a mobile app).

Conditions

Interventions

OTHER

Smartdiabetes

The SMART-DIABETES app will be installed on your mobile phone for use for 4 months (+/- 15 days). Initially, the participants will receive specific information and training on how to use the app. The application will have three specific sections: 1. A personalized physical exercise program (16-18 weeks) designed based on the participant's initial physical condition. 2. Dietary advice consisting of daily diets to be followed throughout the study, individualized according to the baseline nutritional assessment. 3. Records and monitoring: Blood glucose, food, medication, activity, HbA1c (with a minimum of 3 daily blood glucose logs for 3 months, it can calculate the estimated HbA1c), weight, heart rate, ketones. * Bolus calculator: quick insulin dose recommendations. * Digital diary that includes all recorded readings. * Carbohydrate calculator: the patient can calculate the number of carbohydrates they will ingest in grams or servings. * Nutritional da

Sponsors & Collaborators

  • Hospital Universitario Getafe

    collaborator OTHER

  • MG Biomed

    collaborator UNKNOWN

  • SocialDiabetes

    collaborator UNKNOWN

  • Leocadio Rodriguez Mañas

    lead OTHER

Principal Investigators

  • Leocadio Rodriguez Mañas · Hospital Universitario de Getafe

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2025-06-17
Completion
2025-10-30

Countries

  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07591415 on ClinicalTrials.gov